 Makoto Miyazaki
Concepts (571)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stearoyl-CoA Desaturase | 43 | 2026 | 66 | 4.720 |
Why?
| | Vascular Calcification | 9 | 2022 | 110 | 3.940 |
Why?
| | Renal Insufficiency, Chronic | 9 | 2024 | 653 | 2.230 |
Why?
| | Endoplasmic Reticulum | 6 | 2025 | 266 | 1.730 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 9 | 2018 | 209 | 1.650 |
Why?
| | Atherosclerosis | 8 | 2021 | 409 | 1.600 |
Why?
| | Activating Transcription Factor 4 | 5 | 2021 | 22 | 1.580 |
Why?
| | Transcription Factor CHOP | 4 | 2018 | 32 | 1.470 |
Why?
| | Bile Acids and Salts | 3 | 2018 | 164 | 1.370 |
Why?
| | Autophagy | 6 | 2025 | 286 | 1.340 |
Why?
| | Fatty Acids | 20 | 2026 | 450 | 1.230 |
Why?
| | Liver | 22 | 2026 | 1887 | 1.170 |
Why?
| | Endoplasmic Reticulum Stress | 4 | 2021 | 120 | 1.100 |
Why?
| | Calcinosis | 4 | 2014 | 234 | 1.010 |
Why?
| | Mice | 75 | 2026 | 18339 | 0.990 |
Why?
| | Membrane Proteins | 4 | 2025 | 1166 | 0.980 |
Why?
| | Lipids | 12 | 2022 | 710 | 0.920 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2018 | 233 | 0.840 |
Why?
| | Adverse Drug Reaction Reporting Systems | 3 | 2021 | 81 | 0.830 |
Why?
| | Animals | 84 | 2026 | 38058 | 0.780 |
Why?
| | Deoxycholic Acid | 3 | 2022 | 14 | 0.750 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 15 | 0.730 |
Why?
| | Kidney | 10 | 2025 | 1495 | 0.730 |
Why?
| | Mice, Knockout | 30 | 2026 | 3121 | 0.720 |
Why?
| | Stearic Acids | 2 | 2012 | 16 | 0.710 |
Why?
| | Leptin | 9 | 2010 | 245 | 0.710 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2025 | 459 | 0.650 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2018 | 266 | 0.630 |
Why?
| | Vascular Diseases | 2 | 2014 | 251 | 0.600 |
Why?
| | Starvation | 1 | 2019 | 23 | 0.590 |
Why?
| | Isoenzymes | 6 | 2006 | 299 | 0.590 |
Why?
| | Autistic Disorder | 1 | 2022 | 211 | 0.580 |
Why?
| | Vascular Stiffness | 1 | 2024 | 486 | 0.580 |
Why?
| | Cyclin T | 1 | 2018 | 2 | 0.580 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2018 | 18 | 0.570 |
Why?
| | Mice, Inbred C57BL | 27 | 2026 | 5992 | 0.570 |
Why?
| | Lipid Metabolism | 15 | 2018 | 527 | 0.570 |
Why?
| | Metabolomics | 2 | 2026 | 727 | 0.520 |
Why?
| | Energy Metabolism | 5 | 2026 | 935 | 0.510 |
Why?
| | Kidney Diseases | 4 | 2019 | 427 | 0.510 |
Why?
| | Apolipoproteins E | 4 | 2014 | 94 | 0.510 |
Why?
| | Triglycerides | 12 | 2026 | 520 | 0.500 |
Why?
| | Coronary Vessels | 2 | 2022 | 251 | 0.490 |
Why?
| | eIF-2 Kinase | 2 | 2013 | 29 | 0.490 |
Why?
| | Cholesterol | 8 | 2016 | 406 | 0.490 |
Why?
| | Autism Spectrum Disorder | 1 | 2022 | 412 | 0.480 |
Why?
| | Lipogenesis | 4 | 2012 | 62 | 0.480 |
Why?
| | Vaccines | 1 | 2021 | 389 | 0.470 |
Why?
| | Phosphatidylethanolamines | 1 | 2015 | 76 | 0.450 |
Why?
| | Coronary Artery Disease | 2 | 2022 | 741 | 0.440 |
Why?
| | Acute Kidney Injury | 4 | 2026 | 865 | 0.420 |
Why?
| | Fukushima Nuclear Accident | 3 | 2020 | 3 | 0.420 |
Why?
| | Fatty Acid Desaturases | 2 | 2006 | 31 | 0.420 |
Why?
| | Osteogenesis | 4 | 2021 | 208 | 0.410 |
Why?
| | Polycystic Kidney Diseases | 2 | 2025 | 71 | 0.410 |
Why?
| | Disease Models, Animal | 15 | 2026 | 4557 | 0.400 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 5 | 2020 | 38 | 0.400 |
Why?
| | Signal Transduction | 15 | 2024 | 5226 | 0.400 |
Why?
| | Blood Vessels | 2 | 2011 | 171 | 0.380 |
Why?
| | Dietary Fats | 5 | 2007 | 314 | 0.380 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 3 | 2019 | 33 | 0.360 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2025 | 449 | 0.360 |
Why?
| | Japan | 6 | 2021 | 143 | 0.350 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2024 | 452 | 0.350 |
Why?
| | Cells, Cultured | 12 | 2019 | 4154 | 0.340 |
Why?
| | Cisplatin | 3 | 2020 | 334 | 0.330 |
Why?
| | Pharmacovigilance | 2 | 2021 | 23 | 0.330 |
Why?
| | Transcription Factors | 6 | 2006 | 1741 | 0.330 |
Why?
| | Gene Expression Regulation | 7 | 2020 | 2608 | 0.320 |
Why?
| | Amino Acids | 3 | 2026 | 521 | 0.320 |
Why?
| | Fatty Liver | 3 | 2012 | 251 | 0.310 |
Why?
| | DNA-Binding Proteins | 7 | 2008 | 1499 | 0.300 |
Why?
| | Phosphorylation | 9 | 2018 | 1732 | 0.290 |
Why?
| | Humans | 48 | 2025 | 144759 | 0.290 |
Why?
| | Male | 43 | 2026 | 72315 | 0.290 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 9 | 2011 | 55 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1217 | 0.280 |
Why?
| | Mice, Transgenic | 7 | 2018 | 2182 | 0.280 |
Why?
| | Protein Isoforms | 5 | 2019 | 402 | 0.280 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 2 | 2024 | 235 | 0.280 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 2168 | 0.280 |
Why?
| | Inflammation | 6 | 2021 | 2878 | 0.270 |
Why?
| | Orphan Nuclear Receptors | 5 | 2012 | 14 | 0.270 |
Why?
| | Adiposity | 3 | 2010 | 543 | 0.270 |
Why?
| | Oleic Acid | 4 | 2009 | 42 | 0.260 |
Why?
| | Macrophages | 6 | 2021 | 1511 | 0.260 |
Why?
| | Mice, Inbred DBA | 2 | 2018 | 187 | 0.260 |
Why?
| | Cell Proliferation | 4 | 2024 | 2496 | 0.250 |
Why?
| | AMP-Activated Protein Kinases | 5 | 2022 | 190 | 0.250 |
Why?
| | Myocardium | 4 | 2010 | 939 | 0.250 |
Why?
| | Receptors, LDL | 2 | 2018 | 53 | 0.230 |
Why?
| | Insulin Resistance | 3 | 2009 | 1241 | 0.230 |
Why?
| | Transcription, Genetic | 4 | 2020 | 1496 | 0.230 |
Why?
| | Obesity | 8 | 2010 | 3077 | 0.230 |
Why?
| | Fructokinases | 2 | 2016 | 41 | 0.220 |
Why?
| | Epithelial Cells | 4 | 2019 | 1125 | 0.220 |
Why?
| | Lymphoid Tissue | 1 | 2025 | 80 | 0.220 |
Why?
| | Tetraspanins | 2 | 2014 | 18 | 0.210 |
Why?
| | Uric Acid | 2 | 2024 | 166 | 0.210 |
Why?
| | Salmonella Infections | 1 | 2025 | 60 | 0.210 |
Why?
| | Urate Oxidase | 1 | 2024 | 13 | 0.210 |
Why?
| | Deoxyglucose | 1 | 2024 | 51 | 0.210 |
Why?
| | Adipose Tissue | 4 | 2010 | 652 | 0.210 |
Why?
| | Muscle, Skeletal | 6 | 2026 | 1795 | 0.200 |
Why?
| | Glomerulonephritis | 2 | 2021 | 45 | 0.200 |
Why?
| | Cell Line | 5 | 2018 | 2882 | 0.200 |
Why?
| | Diet | 4 | 2021 | 1273 | 0.200 |
Why?
| | Intestine, Small | 2 | 2026 | 166 | 0.200 |
Why?
| | Fructose | 1 | 2004 | 130 | 0.200 |
Why?
| | Salmonella typhimurium | 1 | 2025 | 190 | 0.200 |
Why?
| | Liver X Receptors | 5 | 2012 | 30 | 0.190 |
Why?
| | Sebaceous Glands | 1 | 2002 | 5 | 0.190 |
Why?
| | Kidney Tubules, Proximal | 2 | 2022 | 130 | 0.190 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2005 | 98 | 0.190 |
Why?
| | Fibroblasts | 2 | 2021 | 1034 | 0.190 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2012 | 269 | 0.190 |
Why?
| | Ischemia | 1 | 2026 | 421 | 0.190 |
Why?
| | Isothiocyanates | 1 | 2022 | 3 | 0.180 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2022 | 6 | 0.180 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2022 | 9 | 0.180 |
Why?
| | Metabolome | 1 | 2026 | 384 | 0.180 |
Why?
| | Lysosomes | 2 | 2021 | 128 | 0.180 |
Why?
| | Integrin alpha5 | 1 | 2021 | 2 | 0.180 |
Why?
| | Biomarkers | 5 | 2025 | 4271 | 0.180 |
Why?
| | Folate Receptor 2 | 1 | 2021 | 7 | 0.170 |
Why?
| | Multienzyme Complexes | 4 | 2005 | 67 | 0.170 |
Why?
| | Calibration | 1 | 2022 | 151 | 0.170 |
Why?
| | Parathyroid Hormone | 1 | 2022 | 112 | 0.170 |
Why?
| | Dyslipidemias | 2 | 2022 | 181 | 0.170 |
Why?
| | Judgment | 1 | 2022 | 66 | 0.170 |
Why?
| | Phosphates | 1 | 2022 | 180 | 0.170 |
Why?
| | Chernobyl Nuclear Accident | 1 | 2020 | 5 | 0.170 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.170 |
Why?
| | Kidney Glomerulus | 2 | 2019 | 128 | 0.160 |
Why?
| | Anticholesteremic Agents | 2 | 2012 | 152 | 0.160 |
Why?
| | Fibroblast Growth Factors | 1 | 2022 | 188 | 0.160 |
Why?
| | Spectrum Analysis, Raman | 2 | 2011 | 41 | 0.160 |
Why?
| | Skin | 1 | 2005 | 755 | 0.160 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2020 | 8 | 0.160 |
Why?
| | Amino Acid Sequence | 3 | 2019 | 2155 | 0.160 |
Why?
| | NF-kappa B | 1 | 2024 | 661 | 0.160 |
Why?
| | Podocytes | 2 | 2019 | 80 | 0.160 |
Why?
| | Homeostasis | 2 | 2021 | 640 | 0.160 |
Why?
| | Tissue Distribution | 3 | 2007 | 327 | 0.160 |
Why?
| | Stomach Neoplasms | 1 | 2021 | 126 | 0.160 |
Why?
| | Intestinal Mucosa | 1 | 2026 | 676 | 0.160 |
Why?
| | Down-Regulation | 4 | 2008 | 627 | 0.150 |
Why?
| | Gene Knockout Techniques | 2 | 2018 | 116 | 0.150 |
Why?
| | Cattle | 3 | 2011 | 1000 | 0.150 |
Why?
| | Bayes Theorem | 1 | 2022 | 433 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 128 | 0.150 |
Why?
| | Hepatocytes | 2 | 2019 | 223 | 0.150 |
Why?
| | HeLa Cells | 5 | 2025 | 650 | 0.150 |
Why?
| | Tretinoin | 1 | 2020 | 124 | 0.150 |
Why?
| | Insulin | 7 | 2009 | 2507 | 0.150 |
Why?
| | Fatty Acids, Monounsaturated | 4 | 2009 | 54 | 0.150 |
Why?
| | Kidney Failure, Chronic | 1 | 2025 | 598 | 0.140 |
Why?
| | Blotting, Northern | 6 | 2005 | 204 | 0.140 |
Why?
| | Mitochondria, Liver | 2 | 2012 | 70 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2022 | 266 | 0.140 |
Why?
| | Sepsis | 1 | 2025 | 640 | 0.140 |
Why?
| | Heat-Shock Response | 1 | 2019 | 78 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2021 | 168 | 0.140 |
Why?
| | Receptors, Fc | 1 | 2019 | 55 | 0.140 |
Why?
| | Carrier Proteins | 2 | 2021 | 737 | 0.140 |
Why?
| | Bacterial Proteins | 1 | 2025 | 955 | 0.140 |
Why?
| | Osteopontin | 1 | 2018 | 34 | 0.140 |
Why?
| | Serum Albumin | 1 | 2019 | 147 | 0.140 |
Why?
| | Radiation Dosimeters | 1 | 2017 | 1 | 0.140 |
Why?
| | Background Radiation | 1 | 2017 | 1 | 0.140 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2018 | 69 | 0.140 |
Why?
| | TRPP Cation Channels | 3 | 2024 | 74 | 0.140 |
Why?
| | Rats | 6 | 2024 | 5597 | 0.130 |
Why?
| | Fever | 1 | 2019 | 311 | 0.130 |
Why?
| | Quality Assurance, Health Care | 1 | 2020 | 340 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 257 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2019 | 139 | 0.130 |
Why?
| | Dietary Carbohydrates | 3 | 2007 | 151 | 0.130 |
Why?
| | Interleukin-33 | 1 | 2017 | 45 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 202 | 0.130 |
Why?
| | Adaptive Immunity | 1 | 2018 | 169 | 0.130 |
Why?
| | Disease Progression | 3 | 2021 | 2847 | 0.130 |
Why?
| | Gene Knockdown Techniques | 3 | 2014 | 336 | 0.130 |
Why?
| | Chelating Agents | 1 | 2017 | 71 | 0.130 |
Why?
| | Databases, Factual | 2 | 2020 | 1486 | 0.130 |
Why?
| | Radiation Exposure | 1 | 2017 | 63 | 0.130 |
Why?
| | Ion Pumps | 1 | 2016 | 1 | 0.130 |
Why?
| | Phosphorus | 1 | 2017 | 99 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 862 | 0.120 |
Why?
| | Mice, Mutant Strains | 4 | 2012 | 299 | 0.120 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 69 | 0.120 |
Why?
| | Hypertriglyceridemia | 3 | 2008 | 44 | 0.120 |
Why?
| | Adipocytes, White | 2 | 2022 | 18 | 0.120 |
Why?
| | Heart | 4 | 2010 | 636 | 0.120 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 427 | 0.120 |
Why?
| | Base Sequence | 4 | 2007 | 2190 | 0.120 |
Why?
| | Female | 25 | 2025 | 78271 | 0.120 |
Why?
| | Muscle, Smooth | 1 | 2016 | 153 | 0.120 |
Why?
| | Cell Differentiation | 4 | 2012 | 2050 | 0.120 |
Why?
| | Diet, Fat-Restricted | 2 | 2006 | 79 | 0.120 |
Why?
| | Carbohydrate Metabolism | 2 | 2007 | 60 | 0.120 |
Why?
| | Radiation Monitoring | 1 | 2015 | 16 | 0.110 |
Why?
| | Mitochondria | 3 | 2019 | 984 | 0.110 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 454 | 0.110 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1782 | 0.110 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2016 | 204 | 0.110 |
Why?
| | Radiometry | 1 | 2015 | 56 | 0.110 |
Why?
| | Albuminuria | 1 | 2016 | 190 | 0.110 |
Why?
| | Gamma Rays | 1 | 2015 | 56 | 0.110 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1257 | 0.110 |
Why?
| | Hydrocarbons, Fluorinated | 2 | 2012 | 8 | 0.110 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 628 | 0.110 |
Why?
| | Protein Binding | 3 | 2018 | 2273 | 0.110 |
Why?
| | Metabolic Syndrome | 3 | 2008 | 354 | 0.110 |
Why?
| | Lung Neoplasms | 3 | 2020 | 2637 | 0.110 |
Why?
| | Ketocholesterols | 1 | 2014 | 8 | 0.110 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2014 | 49 | 0.110 |
Why?
| | Immunoglobulin G | 1 | 2019 | 893 | 0.110 |
Why?
| | Osteoblasts | 2 | 2012 | 145 | 0.110 |
Why?
| | Ezetimibe | 1 | 2014 | 24 | 0.110 |
Why?
| | Bone Marrow | 1 | 2016 | 304 | 0.110 |
Why?
| | Azetidines | 1 | 2014 | 45 | 0.100 |
Why?
| | Simvastatin | 1 | 2014 | 60 | 0.100 |
Why?
| | DNA Damage | 1 | 2017 | 430 | 0.100 |
Why?
| | Body Weight | 7 | 2010 | 976 | 0.100 |
Why?
| | Dehydration | 1 | 2013 | 56 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 969 | 0.100 |
Why?
| | Bone Density | 1 | 2017 | 482 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1985 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1263 | 0.100 |
Why?
| | Cholesterol Ester Transfer Proteins | 1 | 2012 | 22 | 0.090 |
Why?
| | Benzoates | 1 | 2012 | 50 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 771 | 0.090 |
Why?
| | Catechin | 1 | 2012 | 22 | 0.090 |
Why?
| | Isoxazoles | 1 | 2012 | 53 | 0.090 |
Why?
| | Nicorandil | 1 | 2012 | 11 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 917 | 0.090 |
Why?
| | Nitric Oxide Donors | 1 | 2012 | 20 | 0.090 |
Why?
| | Minerals | 1 | 2012 | 47 | 0.090 |
Why?
| | DNA Primers | 3 | 2007 | 512 | 0.090 |
Why?
| | Lipoproteins, HDL | 1 | 2012 | 101 | 0.090 |
Why?
| | Middle Aged | 7 | 2025 | 35875 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2017 | 3604 | 0.090 |
Why?
| | Mitochondrial Diseases | 1 | 2012 | 93 | 0.090 |
Why?
| | Oxidation-Reduction | 5 | 2010 | 1087 | 0.090 |
Why?
| | Antioxidants | 2 | 2012 | 549 | 0.090 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2011 | 32 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 710 | 0.090 |
Why?
| | Mice, Nude | 3 | 2021 | 682 | 0.090 |
Why?
| | Molecular Imaging | 1 | 2011 | 55 | 0.090 |
Why?
| | RNA, Messenger | 7 | 2018 | 2832 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1047 | 0.090 |
Why?
| | Aorta | 2 | 2012 | 429 | 0.080 |
Why?
| | Etoposide | 1 | 2011 | 166 | 0.080 |
Why?
| | Plaque, Atherosclerotic | 1 | 2011 | 60 | 0.080 |
Why?
| | Models, Biological | 5 | 2006 | 1821 | 0.080 |
Why?
| | Glucose | 2 | 2007 | 1047 | 0.080 |
Why?
| | Sulfonamides | 2 | 2012 | 580 | 0.080 |
Why?
| | Risk Factors | 3 | 2022 | 10779 | 0.080 |
Why?
| | Alkaline Phosphatase | 1 | 2011 | 145 | 0.080 |
Why?
| | Chenodeoxycholic Acid | 1 | 2010 | 12 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2012 | 200 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 592 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3409 | 0.080 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 2194 | 0.080 |
Why?
| | Mice, Obese | 3 | 2006 | 66 | 0.080 |
Why?
| | Diacylglycerol O-Acyltransferase | 2 | 2006 | 5 | 0.080 |
Why?
| | Cell Movement | 1 | 2014 | 965 | 0.070 |
Why?
| | Agouti Signaling Protein | 1 | 2009 | 2 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2026 | 261 | 0.070 |
Why?
| | Aging | 2 | 2019 | 1966 | 0.070 |
Why?
| | Aged | 5 | 2025 | 25913 | 0.070 |
Why?
| | Cholic Acids | 1 | 2008 | 13 | 0.070 |
Why?
| | Gene Silencing | 2 | 2016 | 205 | 0.070 |
Why?
| | Hypercholesterolemia | 2 | 2006 | 92 | 0.070 |
Why?
| | Microscopy | 1 | 2010 | 156 | 0.070 |
Why?
| | Ceramides | 2 | 2010 | 116 | 0.070 |
Why?
| | Hyperlipidemia, Familial Combined | 1 | 2008 | 2 | 0.070 |
Why?
| | Mutation | 6 | 2018 | 4089 | 0.070 |
Why?
| | Transgenes | 2 | 2006 | 189 | 0.070 |
Why?
| | Diabetic Nephropathies | 1 | 2012 | 318 | 0.070 |
Why?
| | Phosphatidylcholines | 2 | 2008 | 131 | 0.070 |
Why?
| | Blotting, Western | 6 | 2007 | 1187 | 0.070 |
Why?
| | Receptor, Insulin | 2 | 2006 | 94 | 0.070 |
Why?
| | Lipocalin-2 | 2 | 2020 | 79 | 0.070 |
Why?
| | Microsomes | 2 | 2007 | 33 | 0.070 |
Why?
| | Acyltransferases | 2 | 2005 | 78 | 0.070 |
Why?
| | Glycogen | 2 | 2004 | 54 | 0.070 |
Why?
| | Mycological Typing Techniques | 1 | 2007 | 1 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2009 | 361 | 0.070 |
Why?
| | Tumor Burden | 2 | 2020 | 319 | 0.070 |
Why?
| | Histoplasma | 1 | 2007 | 9 | 0.070 |
Why?
| | Histoplasmosis | 1 | 2007 | 15 | 0.070 |
Why?
| | Adipose Tissue, Brown | 2 | 2004 | 59 | 0.070 |
Why?
| | Gluconeogenesis | 1 | 2007 | 83 | 0.060 |
Why?
| | Animal Feed | 2 | 2004 | 53 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2583 | 0.060 |
Why?
| | Time Factors | 4 | 2019 | 7173 | 0.060 |
Why?
| | Sucrose | 1 | 2007 | 112 | 0.060 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2017 | 529 | 0.060 |
Why?
| | Pedigree | 1 | 2008 | 514 | 0.060 |
Why?
| | Blood Pressure | 4 | 2016 | 1769 | 0.060 |
Why?
| | Health Surveys | 2 | 2021 | 518 | 0.060 |
Why?
| | CD36 Antigens | 1 | 2026 | 32 | 0.060 |
Why?
| | Mice, SCID | 2 | 2004 | 369 | 0.060 |
Why?
| | Child | 3 | 2021 | 22633 | 0.060 |
Why?
| | Lipolysis | 2 | 2022 | 46 | 0.060 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2025 | 13 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2006 | 2930 | 0.060 |
Why?
| | Choline-Phosphate Cytidylyltransferase | 1 | 2005 | 3 | 0.060 |
Why?
| | Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.060 |
Why?
| | Carnitine O-Palmitoyltransferase | 4 | 2007 | 49 | 0.060 |
Why?
| | Radiation Dosage | 2 | 2017 | 192 | 0.060 |
Why?
| | Receptors, Retinoic Acid | 2 | 2020 | 42 | 0.050 |
Why?
| | Colitis | 1 | 2008 | 280 | 0.050 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2004 | 2 | 0.050 |
Why?
| | Oxypurinol | 1 | 2024 | 3 | 0.050 |
Why?
| | Structure-Activity Relationship | 2 | 2018 | 570 | 0.050 |
Why?
| | Oxonic Acid | 1 | 2024 | 13 | 0.050 |
Why?
| | Up-Regulation | 2 | 2004 | 851 | 0.050 |
Why?
| | Thermogenesis | 1 | 2004 | 45 | 0.050 |
Why?
| | Lipodystrophy | 1 | 2004 | 14 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2004 | 44 | 0.050 |
Why?
| | Glutathione | 1 | 2026 | 375 | 0.050 |
Why?
| | Xanthine Oxidase | 1 | 2024 | 79 | 0.050 |
Why?
| | Chronic Disease | 1 | 2010 | 1813 | 0.050 |
Why?
| | Cholestasis | 1 | 2006 | 219 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2925 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2024 | 2527 | 0.050 |
Why?
| | Hypothermia | 1 | 2004 | 52 | 0.050 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2003 | 14 | 0.050 |
Why?
| | Transfection | 2 | 2021 | 940 | 0.050 |
Why?
| | Colon | 1 | 2026 | 304 | 0.050 |
Why?
| | Anti-Obesity Agents | 1 | 2004 | 64 | 0.050 |
Why?
| | Body Temperature Regulation | 1 | 2004 | 108 | 0.050 |
Why?
| | Culture Media, Conditioned | 2 | 2016 | 111 | 0.050 |
Why?
| | Foam Cells | 2 | 2016 | 17 | 0.050 |
Why?
| | Cell Membrane | 2 | 2005 | 706 | 0.050 |
Why?
| | Chromatography, Gas | 1 | 2002 | 32 | 0.050 |
Why?
| | Cholesterol, Dietary | 1 | 2002 | 15 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 276 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2005 | 902 | 0.050 |
Why?
| | Neoplasm Invasiveness | 2 | 2014 | 508 | 0.050 |
Why?
| | Cold Temperature | 1 | 2004 | 209 | 0.050 |
Why?
| | Inflammasomes | 1 | 2024 | 146 | 0.050 |
Why?
| | Cytokines | 2 | 2024 | 2061 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2003 | 396 | 0.050 |
Why?
| | Sulfoxides | 1 | 2022 | 3 | 0.050 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 36 | 0.050 |
Why?
| | Thiazolidines | 1 | 2022 | 13 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2003 | 167 | 0.050 |
Why?
| | Dehydroepiandrosterone | 1 | 2002 | 50 | 0.040 |
Why?
| | Protein Transport | 2 | 2019 | 441 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2025 | 371 | 0.040 |
Why?
| | Apoptosis | 3 | 2020 | 2430 | 0.040 |
Why?
| | Aminopterin | 1 | 2021 | 3 | 0.040 |
Why?
| | Muscle Proteins | 1 | 2003 | 244 | 0.040 |
Why?
| | Hypolipidemic Agents | 1 | 2022 | 88 | 0.040 |
Why?
| | RNA | 2 | 2007 | 940 | 0.040 |
Why?
| | Phospholipids | 1 | 2003 | 213 | 0.040 |
Why?
| | Autophagosomes | 1 | 2021 | 20 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 1 | 2006 | 579 | 0.040 |
Why?
| | Social Conditions | 1 | 2020 | 13 | 0.040 |
Why?
| | Enzyme Activation | 3 | 2011 | 766 | 0.040 |
Why?
| | Norway | 1 | 2020 | 45 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 536 | 0.040 |
Why?
| | Proteinuria | 1 | 2021 | 102 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 824 | 0.040 |
Why?
| | Adipocytes | 1 | 2002 | 223 | 0.040 |
Why?
| | Biological Assay | 1 | 2021 | 128 | 0.040 |
Why?
| | Hypophosphatemia, Familial | 1 | 2020 | 4 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2005 | 905 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 53 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5868 | 0.040 |
Why?
| | Butadienes | 1 | 2020 | 37 | 0.040 |
Why?
| | Methotrexate | 1 | 2021 | 240 | 0.040 |
Why?
| | Retinoid X Receptors | 1 | 2020 | 38 | 0.040 |
Why?
| | Immunoblotting | 3 | 2005 | 300 | 0.040 |
Why?
| | Folic Acid | 1 | 2021 | 199 | 0.040 |
Why?
| | 2,4-Dinitrophenol | 1 | 2019 | 9 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2020 | 148 | 0.040 |
Why?
| | Vegetables | 1 | 2021 | 170 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2022 | 284 | 0.040 |
Why?
| | Kidney Medulla | 1 | 2019 | 31 | 0.040 |
Why?
| | Pyrimidinones | 1 | 2020 | 126 | 0.040 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 621 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2019 | 76 | 0.040 |
Why?
| | Liver Regeneration | 1 | 2019 | 46 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 53 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 548 | 0.040 |
Why?
| | Nitriles | 1 | 2020 | 205 | 0.040 |
Why?
| | Oxygen | 1 | 2004 | 995 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 451 | 0.040 |
Why?
| | Testosterone | 1 | 2002 | 419 | 0.040 |
Why?
| | DNA | 1 | 2005 | 1463 | 0.040 |
Why?
| | Pyridones | 1 | 2020 | 199 | 0.030 |
Why?
| | Odds Ratio | 1 | 2021 | 1075 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2020 | 310 | 0.030 |
Why?
| | Fluorocarbons | 2 | 2012 | 143 | 0.030 |
Why?
| | Adult | 5 | 2022 | 40449 | 0.030 |
Why?
| | Urinary Tract | 1 | 2018 | 48 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2012 | 1047 | 0.030 |
Why?
| | Stem Cells | 1 | 2002 | 626 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 760 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 442 | 0.030 |
Why?
| | Weight Loss | 1 | 2002 | 836 | 0.030 |
Why?
| | Mice, Knockout, ApoE | 1 | 2016 | 11 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 3540 | 0.030 |
Why?
| | Dietary Fats, Unsaturated | 2 | 2006 | 24 | 0.030 |
Why?
| | RAW 264.7 Cells | 1 | 2016 | 50 | 0.030 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2018 | 199 | 0.030 |
Why?
| | Nuclear Power Plants | 1 | 2015 | 3 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2021 | 8265 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 358 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 6048 | 0.030 |
Why?
| | Oxidative Stress | 2 | 2012 | 1339 | 0.030 |
Why?
| | Hyperlipidemias | 1 | 2016 | 122 | 0.030 |
Why?
| | Health Status | 1 | 2020 | 836 | 0.030 |
Why?
| | Chemokine CXCL6 | 1 | 2014 | 2 | 0.030 |
Why?
| | Mice, Inbred Strains | 2 | 2006 | 397 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2016 | 194 | 0.030 |
Why?
| | Pyridines | 1 | 2019 | 605 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 320 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2017 | 380 | 0.030 |
Why?
| | History, 21st Century | 1 | 2015 | 219 | 0.030 |
Why?
| | Gene Expression | 3 | 2004 | 1490 | 0.030 |
Why?
| | Creatinine | 1 | 2016 | 506 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 5960 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2017 | 498 | 0.030 |
Why?
| | Blood Glucose | 4 | 2006 | 2327 | 0.030 |
Why?
| | Fatty Acid Synthases | 2 | 2005 | 23 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2013 | 27 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2027 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 31 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2879 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 2014 | 102 | 0.030 |
Why?
| | Immunotherapy | 1 | 2018 | 653 | 0.020 |
Why?
| | ras Proteins | 1 | 2014 | 150 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 253 | 0.020 |
Why?
| | Lipoproteins, VLDL | 2 | 2002 | 21 | 0.020 |
Why?
| | Cytochromes c | 1 | 2012 | 53 | 0.020 |
Why?
| | Macaca fascicularis | 1 | 2012 | 71 | 0.020 |
Why?
| | beta Catenin | 1 | 2014 | 252 | 0.020 |
Why?
| | Succinate Dehydrogenase | 1 | 2012 | 57 | 0.020 |
Why?
| | Pregnancy | 1 | 2005 | 7190 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1387 | 0.020 |
Why?
| | Streptozocin | 1 | 2012 | 21 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 219 | 0.020 |
Why?
| | Cholesterol Esters | 1 | 2011 | 7 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1253 | 0.020 |
Why?
| | Bone Matrix | 1 | 2011 | 6 | 0.020 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 29 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 609 | 0.020 |
Why?
| | Biological Transport | 1 | 2012 | 417 | 0.020 |
Why?
| | Serum | 1 | 2011 | 58 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 574 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 389 | 0.020 |
Why?
| | Molecular Structure | 1 | 2012 | 499 | 0.020 |
Why?
| | Young Adult | 2 | 2020 | 14105 | 0.020 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 125 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 623 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2012 | 198 | 0.020 |
Why?
| | Epididymis | 1 | 2010 | 14 | 0.020 |
Why?
| | Flow Cytometry | 2 | 2006 | 1173 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2010 | 162 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 89 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 168 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 67 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 983 | 0.020 |
Why?
| | Stromal Cells | 1 | 2009 | 124 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 238 | 0.020 |
Why?
| | Oxygen Consumption | 2 | 2002 | 724 | 0.020 |
Why?
| | Feces | 1 | 2012 | 513 | 0.020 |
Why?
| | ATP Binding Cassette Transporter 1 | 1 | 2008 | 13 | 0.020 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2008 | 15 | 0.020 |
Why?
| | Adolescent | 2 | 2020 | 22428 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 455 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 21 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2008 | 118 | 0.020 |
Why?
| | PPAR alpha | 1 | 2007 | 54 | 0.020 |
Why?
| | Dextran Sulfate | 1 | 2008 | 92 | 0.020 |
Why?
| | Sporothrix | 1 | 2007 | 3 | 0.020 |
Why?
| | Paracoccidioides | 1 | 2007 | 2 | 0.020 |
Why?
| | Pigments, Biological | 1 | 2007 | 17 | 0.020 |
Why?
| | Blastomyces | 1 | 2007 | 9 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 2007 | 32 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2008 | 246 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 64 | 0.020 |
Why?
| | Collagen | 1 | 2010 | 456 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 131 | 0.020 |
Why?
| | Lipid Metabolism Disorders | 1 | 2006 | 4 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2007 | 83 | 0.020 |
Why?
| | PPAR gamma | 1 | 2008 | 176 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2006 | 15 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2008 | 510 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2006 | 40 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2025 | 17066 | 0.020 |
Why?
| | Receptors, Leptin | 1 | 2006 | 25 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2010 | 541 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 45 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 490 | 0.020 |
Why?
| | Response Elements | 1 | 2006 | 89 | 0.010 |
Why?
| | Mitochondrial Membranes | 1 | 2006 | 40 | 0.010 |
Why?
| | Lipoproteins, LDL | 1 | 2006 | 119 | 0.010 |
Why?
| | Octoxynol | 1 | 2005 | 13 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2006 | 151 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2006 | 193 | 0.010 |
Why?
| | Endopeptidase K | 1 | 2005 | 18 | 0.010 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 44 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 2006 | 116 | 0.010 |
Why?
| | Acyl-CoA Oxidase | 1 | 2005 | 2 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2010 | 553 | 0.010 |
Why?
| | Microarray Analysis | 1 | 2005 | 117 | 0.010 |
Why?
| | Ethanolaminephosphotransferase | 1 | 2005 | 1 | 0.010 |
Why?
| | Glycerol-3-Phosphate O-Acyltransferase | 1 | 2005 | 1 | 0.010 |
Why?
| | Fish Oils | 1 | 2005 | 26 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2006 | 321 | 0.010 |
Why?
| | Serine C-Palmitoyltransferase | 1 | 2004 | 8 | 0.010 |
Why?
| | Thinness | 1 | 2005 | 99 | 0.010 |
Why?
| | Sphingomyelins | 1 | 2004 | 22 | 0.010 |
Why?
| | Acyl Coenzyme A | 1 | 2004 | 31 | 0.010 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2004 | 17 | 0.010 |
Why?
| | Serine | 1 | 2005 | 145 | 0.010 |
Why?
| | Glycerol | 1 | 2005 | 90 | 0.010 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2006 | 178 | 0.010 |
Why?
| | Palmitic Acid | 1 | 2004 | 42 | 0.010 |
Why?
| | Homozygote | 1 | 2005 | 199 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2005 | 369 | 0.010 |
Why?
| | Catalysis | 1 | 2005 | 322 | 0.010 |
Why?
| | Receptors, Adrenergic, beta-3 | 1 | 2004 | 4 | 0.010 |
Why?
| | Uncoupling Protein 1 | 1 | 2004 | 17 | 0.010 |
Why?
| | Echocardiography | 1 | 2007 | 652 | 0.010 |
Why?
| | Plasmids | 1 | 2005 | 379 | 0.010 |
Why?
| | Cysteine | 1 | 2005 | 210 | 0.010 |
Why?
| | Fats | 1 | 2004 | 17 | 0.010 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2004 | 17 | 0.010 |
Why?
| | Trans-Activators | 1 | 2006 | 405 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 416 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2004 | 158 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2005 | 214 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 226 | 0.010 |
Why?
| | Ion Channels | 1 | 2004 | 129 | 0.010 |
Why?
| | Glucose Transporter Type 4 | 1 | 2003 | 38 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6429 | 0.010 |
Why?
| | Epitopes | 1 | 2005 | 485 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2003 | 56 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2006 | 675 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 869 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 499 | 0.010 |
Why?
| | Body Temperature | 1 | 2004 | 229 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1054 | 0.010 |
Why?
| | Muscles | 1 | 2004 | 333 | 0.010 |
Why?
| | Hydroxymethylglutaryl CoA Reductases | 1 | 2002 | 13 | 0.010 |
Why?
| | Protein Conformation | 1 | 2005 | 946 | 0.010 |
Why?
| | Vacuoles | 1 | 2002 | 38 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2002 | 124 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 2002 | 85 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1370 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2002 | 156 | 0.010 |
Why?
| | Cell Size | 1 | 2002 | 92 | 0.010 |
Why?
| | Gene Dosage | 1 | 2002 | 148 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2004 | 262 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2002 | 427 | 0.010 |
Why?
| | Infant | 1 | 2015 | 10034 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2002 | 758 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11787 | 0.010 |
Why?
| | Eating | 1 | 2002 | 389 | 0.010 |
Why?
| | Phylogeny | 1 | 2004 | 1016 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1627 | 0.010 |
Why?
| | Body Mass Index | 1 | 2005 | 2438 | 0.010 |
Why?
|
|
Miyazaki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|